The Asian Development Bank (AfDB) and the government signed $ 150 million loan agreements last week, under the Asia-Pacific Vaccine Access Facility (APVAX) for the purchase vaccines and other related consumables.
The loan is part of the AfDB’s $ 9 billion Asia-Pacific Vaccine Access Facility (APVAX) launched in December 2020 to provide rapid and equitable vaccine support to developing member countries of the AfDB. Secretary of Treasury and Ministry of Finance SR Attygalle signed the loan agreement for the Government of Sri Lanka and AfDB Country Director for Sri Lanka Chen Chen signed on behalf of AfDB. “The AfDB is committed to reducing this pandemic and minimizing its negative socio-economic and health effects,” Chen said.
“We are in constant contact with the government and development partners to help the country recover from the pandemic,” he said.
The loan will help finance the purchase of safe and effective coronavirus disease (Covid-19) vaccines, contributing to the government’s goal of reaching 80% vaccine coverage by 2023.
This intervention, which targets the entire country through the 26 health districts of the 9 provinces, will ensure that geographically, socially and economically disadvantaged populations are protected from Covid-19 and its effects. Attygalle said: “The AfDB has been a committed partner, providing assistance where it is most needed.
This intervention will certainly boost the country’s immunization campaign and help improve essential infrastructure and systems in the health sector.